Rankings
▼
Calendar
ARCT FY 2024 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$138M
-12.3% YoY
Gross Profit
$138M
100.0% margin
Operating Income
-$96M
-69.1% margin
Net Income
-$81M
-58.5% margin
EPS (Diluted)
$-3.00
Cash Flow
Operating Cash Flow
-$60M
Free Cash Flow
-$60M
Stock-Based Comp.
$38M
Balance Sheet
Total Assets
$344M
Total Liabilities
$103M
Stockholders' Equity
$241M
Cash & Equivalents
$237M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$138M
$158M
-12.3%
Gross Profit
$138M
$158M
-12.3%
Operating Income
-$96M
-$78M
-22.3%
Net Income
-$81M
-$30M
-172.3%
← Q4 2023
All Quarters
Q1 2024 →